Results 31 to 40 of about 25,585 (256)

M-BEV: Masked BEV Perception for Robust Autonomous Driving

open access: yesProceedings of the AAAI Conference on Artificial Intelligence
3D perception is a critical problem in autonomous driving. Recently, the Bird’s-Eye-View (BEV) approach has attracted extensive attention, due to low-cost deployment and desirable vision detection capacity. However, the existing models ignore a realistic scenario during the driving procedure, i.e., one or more view cameras may be failed, which largely ...
Siran Chen   +3 more
openaire   +3 more sources

Aerodynamics-guided machine learning for design optimization of electric vehicles

open access: yesCommunications Engineering
The transition to electric vehicles is driving a fundamental shift in the automobile design process. Changes in constraints afforded by the absence of a combustion engine create new opportunities for modifying vehicle geometries.
Jonathan Tran   +6 more
doaj   +1 more source

Microfluidic Engineering of Microgels: A Review of Emerging Technologies, Materials, Fabrication Strategies, and Applications

open access: yesAdvanced Healthcare Materials, EarlyView.
Recent advances in microfluidic technologies for microgel fabrication are critically reviewed, highlighting the capabilities and limitations of major microfluidic platforms and discussing how platform design, material selection, and crosslinking strategies influence microgel architecture and functionality. Current challenges and future opportunities in
Afshin Abrishamkar   +6 more
wiley   +1 more source

Impacts on Histological Features and 11C-Methyl-L-methionine Uptake After “One-Shot” Administration with Bevacizumab Before Surgery in Newly Diagnosed Glioblastoma

open access: yesTranslational Oncology, 2019
BACKGROUND: Bevacizumab (BEV), an antiangiogenic agent, induces dramatic normalization of the tumor vasculature in glioblastoma. This study aimed to clarify how one-time administration of BEV changes histological features in glioblastoma and how ...
Takaaki Beppu   +6 more
doaj   +1 more source

Advanced Materials for Biologics Delivery to Brain Tumors

open access: yesAdvanced Materials, EarlyView.
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng   +4 more
wiley   +1 more source

Exchange Value and Affect: Bourdieu and the Self

open access: yes, 2005
A meeting ground for mainstream social theory and contemporary feminist theory. Brings feminist theory face to face with Pierre Bourdieu s social theory. Demonstrates how much Bourdieu s theory has to offer to contemporary feminism. Comprises a series of
Skeggs, Bev
core   +6 more sources

Multilevel Embedding and Dropout for Improved 3D Object Detection in Autonomous Driving Systems

open access: yesAdvanced Robotics Research, EarlyView.
A plug‐in framework for RoI‐based 3D object detectors exploits previously untapped multi‐level information within RoI features. Its novel multi‐level embedding and dropout strategy enables the detection head to generate predictions at different feature levels.
Xiaohu Lu, Hayder Radha
wiley   +1 more source

M-BEV: Masked BEV Perception for Robust Autonomous Driving [PDF]

open access: yes, 2023
3D perception is a critical problem in autonomous driving. Recently, the Bird-Eye-View (BEV) approach has attracted extensive attention, due to low-cost deployment and desirable vision detection capacity.
Ma, Yue   +3 more
core   +1 more source

Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma

open access: yesBMC Cancer, 2019
Background Assess benefit of salvage bevacizumab (BEV) at time of symptomatic progression in patients with refractory glioblastoma (GBM). Methods Patients managed with adjuvant long course chemo-radiation therapy for GBM were entered into a prospective ...
Moire Cuncannon   +6 more
doaj   +1 more source

Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer

open access: yesBMC Cancer, 2020
Background First-line treatment with FOLFOXIRI plus bevacizumab (BEV) is highly effective and regarded as one of the standards-of-care for patients with metastatic colorectal cancer (mCRC), despite the high incidence of neutropenia and diarrhea as side ...
Masaaki Miyo   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy